Rubis, Nadia
53  Ergebnisse:
?
 
?
 
?
4

Safety and Preliminary Efficacy of Mesenchymal Stromal Cell..:

Perico, Norberto ; Remuzzi, Giuseppe ; Griffin, Matthew D....
Journal of the American Society of Nephrology.  34 (2023)  10 - p. 1733-1751 , 2023
 
?
6

The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pat..:

Derwich, Aleksandra ; Sykutera, Monika ; Bromińska, Barbara...
International Journal of Molecular Sciences.  24 (2023)  13 - p. 10952 , 2023
 
?
 
?
 
?
14

A GWAS in the pandemic epicenter highlights the severe COVI..:

Matteo Breno ; Marina Noris ; Nadia Rubis...
http://www.sciencedirect.com/science/article/pii/S2589004223017066.  , 2023
 
?
15

Safety and preliminary efficacy of mesenchymal stromal cell..:

Perico, Norberto ; Remuzzi, Giuseppe ; Griffin, Matthew D...
Perico , N , Remuzzi , G , Griffin , M D , Cockwell , P , Maxwell , A P , Casiraghi , F , Rubis , N , Peracchi , T , Villa , A , Todeschini , M , Carrara , F , Magee , B A , Ruggenenti , P L , Rota , S , Cappelletti , L , McInerney , V , Griffin , T P , Islam , M N , Introna , M , Pedrini , O , Golay , J , Finnerty , A A , Smythe , J , Fibbe , W E , Elliman , S J , O'Brien , T & NEPHSTROM Trial Consortium 2023 , ' Safety and preliminary efficacy of mesenchymal stromal cell (ORBCEL-M Cell) therapy in diabetic kidney disease: a randomized clinical trial (NEPHSTROM) ' , Journal of the American Society of Nephrology . https://doi.org/10.1681/ASN.0000000000000189.  , 2023
 
1-15